NBR rallied 11% on the week to $83.59 after its Q2 print landed better than feared — the stock jumped 8.7% on July 29 — yet short sellers have not folded, and options traders remain more defensive than the move suggests.
The earnings reaction was the clearest positive signal. The stock closed at $75.64 heading into the print, then surged 8.7% the next session and added a further 6.3% over five days. That erases most of the pre-earnings selldown and puts NBR up roughly 7% on the month. The next scheduled event is October 29, giving the current setup time to either consolidate or erode.
Short interest has barely budged despite the rally — that is the week's most important tension. Bears hold 7.2% of the free float, up roughly 1.7% on the week even as the stock climbed double digits. The monthly trend is friendlier for longs, with SI down around 4% over 30 days, but the week-over-week rebuild suggests some shorts are either adding or refusing to cover at current prices. Borrow conditions give them no urgency to move: availability is deeply loose at around 1,347%, meaning shares available to borrow vastly outnumber those already shorted, and borrowing costs are a negligible 0.52%. There is no squeeze pressure here. The options market reinforces the caution. The put/call ratio runs at 1.97, just above its 20-day average of 1.93 — structurally elevated relative to its 52-week low of 0.84 — and has barely moved despite the post-earnings bounce. Defensive positioning has not unwound.
The Street is split, and the week's analyst activity captures that divide precisely. Piper Sandler raised its target from $120 to $130 on July 30, maintaining an Overweight rating — a direct vote of confidence after the Q2 numbers. Barclays pushed the other way, cutting its target from $99 to $93 on August 5 while staying at Equal-Weight, even with the stock trading through its revised target. The mean price target across the Street sits at roughly $107, implying around 27% upside from current levels, but that aggregate conceals a wide distribution. Susquehanna is at $85, effectively at the money. Morgan Stanley's Overweight carries a $100 target. The bull case centres on SANAD rig builds, day margins running at $17,931 and rising, and the $625 million Quail Tools divestiture strengthening the balance sheet. Bears point to the $2.5 billion in debt maturities over the next seven years and the $30 million Mexico collections shortfall that hit Q3 2025 free cash flow. The EV/EBITDA multiple has eased to 3.6x over the past month — down from higher levels — which partially supports the bull argument on value, though the factor score for forward EPS momentum is near the bottom of the universe at the 7th percentile.
Institutional flow offers a mild bullish lean. BlackRock added around 20,000 shares in its most recent filing to reach 7.7% of the company. American Century and Dimensional both built positions, the latter adding roughly 133,000 shares. On the other side, Adage trimmed by 520,000 shares and Miller Value Partners cut by 158,000 — though both filings are from March and may not reflect post-earnings positioning. Insider data is stale at over five months old and should not be read into the current setup.
What to watch next is whether short interest continues to rebuild through the post-earnings consolidation — a further week-over-week increase without a corresponding price decline would suggest shorts are pressing a fresh thesis rather than simply refusing to cover a legacy position.
See the live data behind this article on ORTEX.
Open NBR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
